Delivery Order SPE2DB22D9206-SPE2DB23FV5EK

Award Date 7/17/23
Potential Completion Date 8/7/23
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at eleven thousand six hundred eighty-five dollars and eighty-one cents to DMS Pharmaceutical Group Incorporated. The order is for forty-five hundred sixty thousand eight hundred ninety-five units of EXPAREL 266 MG/20 ML vials to be delivered to a location in Park Ridge, Illinois. Performance will take place between May 8 and May 30, 2023. No set aside designation or subcontractors were identified. The Defense...
The Defense Logistics Agency awarded a $13,092.97 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The place of performance is Park Ridge, Illinois, with work scheduled to be completed by July 7, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics supply chain, stocking over five million items for military customers worldwide. This delivery order for analgesic vials supports the Agency's mission to...
The Defense Logistics Agency awarded a $6,072.18 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The order is for 20mL vials of the specified medication to be delivered to a location in Park Ridge, Illinois, with performance required between June 29, 2023 and July 21, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order is likely intended to replenish...
The Defense Logistics Agency awarded a $49,762 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order is for 20mL vials of the specified medication to be delivered to a location in Park Ridge, Illinois between August 2nd and August 23rd, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics support in defense of critical supplies. No set aside...
The Defense Logistics Agency awarded a $14,928.66 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML VIAL 20ML. The place of performance is Park Ridge, Illinois. The contract period runs from June 7, 2023 through June 29, 2023. The Defense Logistics Agency is the logistics combat support agency of the Department of Defense, responsible for worldwide logistics support in procurement, distribution and maintenance for all military services and several...
The Defense Logistics Agency (DOD) awarded a $7,464.33 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML VIAL 20ML. The place of performance is Park Ridge, Illinois. The contract period runs from July 20, 2023 through August 10, 2023. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports procurement and distribution of pharmaceuticals and medical supplies. This delivery order provides a specific pharmaceutical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand one hundred forty-four dollars and thirty-six cents ($12,144.36) to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML VIAL 20ML. The place of performance will be in Park Ridge, Illinois. The period of performance is from August 2, 2023 through August 23, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports military readiness by procuring,...
The Defense Logistics Agency awarded a delivery order valued at $24,881.10 to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML VIAL 20ML. The prime contractor will deliver the pharmaceutical product to a location in Park Ridge, Illinois under a firm fixed price contract. The Defense Logistics Agency supports Department of Defense programs by procuring food, clothing, medicines, fuel and other necessary supplies. This delivery order for an extended-release local anesthetic drug will...
The Defense Logistics Agency awarded a $24,881.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML VIAL 20ML. The place of performance is Park Ridge, Illinois. The contract period of performance runs from August 8, 2023 through August 29, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency procures medical supplies and pharmaceuticals to support the U.S. military healthcare system, so this delivery order is...
The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products. The place of performance is Park Ridge, Illinois. The contract period runs from August 23, 2023 through September 14, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in warfare and national emergencies, fulfilling a critical...
  • SPE2DB22D9206
    Indefinite Delivery Contract
  • SPE2DB22D9206-SPE2DB23FV5EK
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at eleven thousand six hundred eighty-five dollars and eighty-one cents to DMS Pharmaceutical Group Incorporated. The order is for twenty vials of EXPAREL 266 MG/20 ML, to be delivered to a location in Park Ridge, Illinois by August 7, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics support system and oversees medical commodity management for all military branches, indicating this order is likely to support treatment needs within the military health system. No set aside designation or subcontractors are noted.

Generated 12/20/23, 3:08 AM